Einstein/Montefiore Department of Medicine

DOM COVID-19 Resources



The COVID-19 Resource page is a repository of valuable information gathered by the Department of Medicine during the epidemic. It will continue to be updated daily.


Please Support Einstein Researchers Find Cures for COVID-19

The COVID-19 epidemic is one of the most significant public health crises of the twenty-first century. Your donation to COVID-19 research will help Einstein and Montefiore scientists find treatments for this deadly virus.



Montefiore COVID-19 Treatment Plans and Protocols

COVID-19 Treatment Plans Portal (Includes all protocols and treatment guidelines)

Video Lectures:

  • LTV Ventilator 1200 (Carefusion) (Sami Nachman, MD) Video 
  • Optimizing Ventilator Settings for Patients Outside of an ICU
    During the COVID-19 Pandemic 
    (Daniel G. Fein, MD) Video 
  • Sedation and Analgesia Guideline for Patients Not in the ICU (Dr. Krystal Clevan) Video 
  • Management of Respiratory Failure During the COVID-19 Pandemic: Essentials for Non-Intensivists (Drs. Divya Reddy and Vivek Murthy) Video 
Returning an N95 Mask for Reprocessing
Created by Hospital Epidemiologist Dr. Theresa Madaline pdf

Prone Position for Spontaneously Breathing COVID-19 Patients
For benefits of prone positioning and instructions click here. Created by JT Tina Chen, MD, and Michelle Gong, MD, MS.

Updated and New Guidelines from Dr. Theresa Madaline, Montefiore Healthcare Epidemiologist: 

  • Updated: MHS COVID-19 Situation Summary 5.12.20 pdf 
  • Updated: Clinical Pathway and Evaluation Guide 5.12.20 pdf
    Highlights include minor clarifications on outpatient pathways' new guidance requiring PCR testing for SNF discharges' requirement for SNF staff to have twice weekly SARS-CoV-2 PCR tests; updated SNF staff OHS guidance; and a grid to assist in isolation decision based on PCR results and duration of illness.
  • New: MHS Guidelines for Remdesivir Access 5.12.20  pdf 
  • Antibody Testing Interpretation Guides for Associates (5.6.20) pdf 
  • Antibody Testing Interpretation Guides for Providers (5.6.20) pdf 
  • Collaborative OHS/ID Statement for Associates Re: COVID-19 (5.6.20) pdf 
  • Skin Care Guidelines for N95 Mask Use from NPIAP.  Preventing Injury Statement (5.6.20) pdf 

Clinical Trials

NIH Remdesivir Trial ACTT-2 (PI: Barry Zingman)
An adaptive, randomized, placebo-controlled clinical trial to assess therapies for hospitalized patients with moderate to severe COVID-19. The second phase of the trial will begin next week at Moses and Weiler.  All study patients will receive IV remdesivir and will be randomized to receiving either the JAK 1/2 inhibitor baricitinib or a matching placebo.  For information email COVID-NIH-AdaptiveTreatmentTrial-StudyTeam-MOSES@montefiore.org (MMC Moses Internal Users only) or COVID-NIH-AdaptiveTreatmentTrial-StudyTeam-WEILER@montefiore.org (MMC Weiler Internal Users only); consult Infectious Diseases; or call 718-920-5224. 

COVID-I9 Convalescent Plasma (PI Liise-anne Pirofski; Co-PI Hyunah Yoon)
The randomized placebo-controlled trial is a collaboration with NYU. The trial will enroll 300 hospitalized patients with COVID-19 respiratory symptoms. Half of these individuals will receive plasma that contains antibodies to the SARS-CoV-2 coronavirus, while the remaining half will receive a placebo. Candidates for the clinical trial have had respiratory symptoms for less than a week or have been in the hospital for 72 hours or less and require some supplemental oxygen. For information see ClinicalTrials.gov: NCT04364737.  Read Einstein press release.
Outcomes Related to COVID-19 treated with Hydroxychloroquine among In-patients with symptomatic Disease (ORCHID) (PI Michelle Gong)
ORCHID is a blinded, multicenter, placebo-controlled randomized clinical trial evaluating hydroxychloroquine for the treatment of adults hospitalized with COVID-19. This trial is funded by the NHLBI and conducted by PETAL Clinical Trials Network. For more information please email orchid@montefiore.org. Einstein press release.

Regeneron Sarilumab Trial Now in Phase III (Site PI: Michelle Gong)
An adaptive, randomized, placebo-controlled clinical trial assessing the efficacy of the IL-6 receptor antibody sarilumab to treat critically ill COVID-19 adults on mechanical ventilation or high flow nasal cannula. This is a Phase 3 trial to determine clinical benefit after a Phase 2 trial showed that Sarilumab significantly decreased C-reactive protein, a marker of inflammation with the possible improvement of clinical outcomes among critically ill patients who have higher levels of interleukin-6.  To enroll or for more information email Dr. Michael Aboodi at maboodi@montefiore.org

Updated: Cytodyn Leronlimab Trial (Site PI: Harish SeethamrajuMD)
Patients are eligible if they are either outpatients or are inpatients admitted at Moses. For information email LeronlimabDrugTrial@montefiore.org


Breaking the Blind 

NIH/NIAID COVID Remdesivir Preliminary Clinical Trial Results | Explained
Dr. Barry Zingman helps viewers understand the significance of the preliminary results of the NIH/NIAID clinical trial of remdesivir for hospitalized COVID patients. Dr. Zingman is leading the trial at Montefiore Einstein. Video

COVID-19-Related Presentations

Chair of Medicine Updates on COVID-19 Effort

  • 4.23.20 Chair of Medicine Update #3 on DOM COVID-19 Effort
    Presented by Yaron Tomer, MD. Link to slidesvideo 
  • 4.7.20 Chair of Medicine Update #2 on DOM COVID-19 Effort
    Presented by Yaron Tomer, MD. View slides pdf. This presentation was not recorded.   
  • 3.24.20 Chair of Medicine Update #1 on DOM COVID-19 Effort (see highlights). This presentation was not recorded.  

Medicine Grand Rounds, Webinars and Town Halls

  • 07.16.2020Video 
    Diabetes, Multimorbidity, and COVID-19, Speakers: Shivani Agarwal, MD, MPH, Assistant Professor, Department of Medicine (Endocrinology) and Nir Barzilai, Professor, Department of Medicine (Endocrinology); Professor, Department of Genetics; Ingeborg and Ira Leon Rennert Chair in Aging Research; Director, Institute for Aging Research
  • 07.09.20 Video 
    The Impact of COVID-19 on Renal Disease; Speaker: Neelja Kumar, MD, Division of Nephrology
  • 07.02.20 Video 
    Facing the Surge: Montefiore Pulmonary/Critical Care Medicine and the COVID-19 Crisis of Spring 2020 in the Bronx; Speaker: Adam Keene, MD, Division of Critical Care/Pulmonary Medicine
  • 06.25.20Video 
    COVID-19 Related Myocarditis; Speaker: Sasha Vukelic, MD; Division Cardiology
  • 06.23.20Video 
    Hypercoagulability and Thrombosis in COVID-19; Speaker: Margarita Kushnir, MD; Division of Hematology
  • 06.11.20Video 
    Structural Racism and COVID-19; Speakers: Matthew Akiyama, MD; Chanelle Diaz, MD; Iman Hassan, MD; Tiffany Lu, MD; Jon Ross, MD; Shani Scott, MD, Division of General Internal Medicine
  • 06.04.20 - Slides pdf and video 
    COVID-19 Medicine Grand Rounds: The Inpatient Medical Service During the COVID-19 Pandemic, Speakers: Drs. Jessica Dekhtyar, Jessica Pacifico, Keron Lezama, Shitij Arora, Division of Hospital Medicine 
  • 06.03.20Video 
    What We Can Learn From Convalescent COVID 19 Patients: Antibody Responses And Development of Monoclonal Antibodies; Speakers: Johanna Daily, MD and Kartik Chandran, PhD
    Link to Johanna Daily's slides pdf Kartick Chandran's slides pdf and Video (Password: 5M*f9$^1) 
  • 05.27.20 - (Slides only pdf)
    Convalescent Plasma for COVID-19; Speaker: Liise-anne Pirofski, MD, Chief, Division of Infectious Diseases. Slides pdf.
  • 05.21.20, Medicine Grand Rounds: The Impact of COVID-19 on the Elderly in Our Community
  • Presented by Amy Ehrlich, MD, Professor of Medicine; Associate Chief, Division of Geriatrics and Tia Powell, MD, Professor in the Departments of Epidemiology & Population Health and Psychiatry and Behavioral Sciences. View video 
  • 05.12.20, MHS COVID-19 Webinar
    Presented by Theresa Madaline, MD, Montefiore Healthcare Epidemiologist; Webinar  and pdf 
  • 05.05.20, MHS COVID-19 Webinar
    Presented by Theresa Madaline, MD, Montefiore Healthcare Epidemiologist Video  
  • 04.28.20, MHS COVID-19 Webinar and Situation Summary
    Presented by Theresa Madaline, MD, Montefiore Healthcare Epidemiologist. Webinar Video and slidesSituation Summary pdf 
  • 4.22.20 COVID-19 Update: Moses-Weiler Internal Medicine Residency Program; Lauren Shapiro, MD, Director, Residency Program pdf 
  • 4.23.20 DFSM Grand Rounds: Naming Racism (Again | Still) in the Midst of a Pandemic; Speaker Camara Phyllis Jones, MD, MPH, PhD, 2019-2020 Evelyn Green Davis Fellow, Radcliffe Institute for Advanced Study, Harvard University. Link.
  • 4.16.20 Town Hall: Supporting Family and Child Emotional Health During COVID-19; presented by Sandra S. Pimental, PhD, Chief of Child and Adolescent Psychology, Associate Director of Psychology Training, and Associate Professor of Clinical Psychology in the Department of Psychiatry and Behavioral Medicine. Link to slides and tip sheets  
  • 4.14.20 Special Medicine Grand Rounds: Psychological PPE-Enhancing Resilience in the Face of Stress. Presented by Carol Bernstein, MD, Professor and Vice-Chair, Faculty Development and Wellbeing Departments of Psychiatry and Behavioral Science. View slides and video (due to technical glitches, there will be some pauses.) Access Password: d8!?U*2%  
  • 4.9.20 Medicine Grand Rounds:An Evolving Global Pandemic; Speaker: Divya Reddy, MBBS, MPH. Video here  
  • 4.7.20 COVID-19 Webinar: Theresa Madaline, MD, Montefiore Healthcare Epidemiologist Video Link  
  • 3.31.20 Special Grand Rounds Update on COVID-19; Speaker, Lindsey Baden, MD, Director of Clinical Research in the Division of Infectious Diseases at the Brigham and Women’s Hospital. Video here
  • 3.31.20 COVID-19 Update: Webinar:Theresa Madaline, MD, Montefiore Healthcare Epidemiologist. Link to Video 

DOM Daily COVID-19 Update Newsletter Archive


Resources for Healthcare Workers

Montefiore’s Mental Health Services During COVID-19 

  • Caregiver Support Centers at Moses, CHAM, Weiler, Wakefield for use by staff for refreshments, respite and support. Hours are 8 a.m. - 8 p.m. at Moses and 11 a.m. - 5 p.m. Mondays-Fridays at the other locations.
  • Staff Emotional Support Line: 8 a.m. - 10 p.m. 7 days/week, 718-920-8844, staffed by Montefiore psychologists, social workers, and psychiatrists.
  • Swift Montefiore Associate Referral Team (SMART): Expedited referrals to Psychiatry for short-term treatment of colleagues with COVID 19 related distress. Please email MEPA@montefiore.org including the following information: 1. Name, 2. DOB, 3. Insurance, 4. Chief Complaint, 5. Requested services (e.g., psychotherapy, medications) if known.  
  • Montefiore EAP programs: For employees covered by Empire BC/BS: 844-300-6072 (24/7 line) or email clientservice@carebridge.com. For 1199 SEIU employees: Member Assistance Program 646-473-6900.
  • Montefiore Emotional Support Allies (MESA): New program that will pair frontline clinicians with Montefiore mental health partners who will proactively reach out for periodic check-ins; clinicians can opt-out, otherwise will be contacted.
  • Additional Staff Emotional Support Resources on eMontefiore COVID-19 site.


SMART Parenting Skills Workshop
The Swift Montefiore Associate Referral Team for Family Support (SMART-FAM) of Montefiore's Department of Psychiatry and Behavioral Sciences will offer a Parenting Skills Group for Montefiore Associates. The series of video sessions will be held on Fridays, from 2 p.m. to 3 p.m. on May 8, 15, 22, and 29. Lead by: Dr. Jenny Seham, Attending Psychologist and Abby Bailin, MA, Psychology Intern. For details see flyer.


NYC Offers Free Hotel Rooms for COVID-19 Isolation
The City of New York's COVID-19 Hotel Program provides free hotel stays to eligible New Yorkers who cannot isolate where they live and frontline workers in the healthcare industry who wish to reduce the risk of transmission at home. This will help New York City stop the spread of COVID-19.
  • If you are a healthcare worker or volunteer in a healthcare setting and are unable to live apart from others in your household, make your hotel reservation.
  • If you are a healthcare provider authorized to refer patients to hotels, access the healthcare providers portal.
  • If you are sick with what might be COVID-19 and are unable to live apart from others in your household, a community healthcare provider can determine if you are eligible to stay in a COVID-19 hotel. (See the listing of enrolled/authorized providers below under the Community Healthcare Providers section of this website page.)
  • If you are a hospital seeking to refer a patient to a hotel, contact NYC Health + Hospitals.
Click here to log in